Skip to content

13F-HR filed by ARCH Venture Management, LLC

ARCH Venture Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 10 holding rows worth $677,093,705.

Accession
0001012975-26-000461
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 10 entries on the cover page, a total value of $677,093,705 stated on the cover page (in dollars after the unit check, H1), rows summing to $677,093,705 with VALUE read as dollars as filed, 13F file number 028-19358. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MAZE THERAPEUTICS INC COM578784100Stock4,120,053$122,983,582dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock3,728,738$116,672,212dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM12,916,663$115,733,300dollars as filed
ERASCA INC COM29479A108Stock7,091,557$114,741,392dollars as filed
BEAM THERAPEUTICS INC07373V105COM4,540,132$108,191,346dollars as filed
LYELL IMMUNOPHARMA INC COM NEW55083R203Stock3,247,162$65,138,070dollars as filed
GENERATE BIOMEDICINES INC370920100COMMON STOCK1,944,426$24,305,325dollars as filed
10X GENOMICS INC CL A COM88025U109Stock217,834$4,624,616dollars as filed
GOSSAMER BIO INC COM38341P102Stock8,055,916$2,646,368dollars as filed
Q32 BIO INC746964105Common Stock320,482$2,057,494dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-26-000461this filing2026-05-15acceptance time not in the bulk data set